Cargando…

Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world

In the context of the current coronavirus disease 2019 (COVID-19) pandemic, we conducted a meta-analysis on the effects of chloroquine derivatives in patients, based on unpublished and published reports available publicly on the internet as of 27 May 2020. The keywords ‘hydroxychloroquine’, ‘chloroq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Million, M., Gautret, P., Colson, P., Roussel, Y., Dubourg, G., Chabriere, E., Honore, S., Rolain, J.-M., Fenollar, F., Fournier, P.-E., Lagier, J.-C., Parola, P., Brouqui, P., Raoult, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558783/ https://www.ncbi.nlm.nih.gov/pubmed/33088574 http://dx.doi.org/10.1016/j.nmni.2020.100709

Ejemplares similares

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Noncontiguous finished genome sequence and description of Paenibacillus antibioticophila sp. nov. GD11(T), the type strain of Paenibacillus antibioticophila
por: Dubourg, G., et al.
Publicado: (2015)

Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)

Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France
por: Edouard, S., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

First documentation of Rickettsia conorii infection (strain Indian tick typhus) in a Traveler.
por: Parola, P, et al.
Publicado: (2001)

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

Chloroquine and COVID-19: A western medical and scientific drift?
por: Million, Matthieu, et al.
Publicado: (2020)

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
por: Rolain, Jean-Marc, et al.
Publicado: (2007)

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
por: Devaux, Christian A., et al.
Publicado: (2020)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults
por: Colson, Philippe, et al.
Publicado: (2020)

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

The Antioxidants Glutathione, Ascorbic Acid and Uric Acid Maintain Butyrate Production by Human Gut Clostridia in The Presence of Oxygen In Vitro
por: Million, Matthieu, et al.
Publicado: (2020)

Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?
por: Dubourg, Grégory, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

‘Collinsella phocaeensis’ sp. nov., ‘Clostridium merdae’ sp. nov., ‘Sutterella massiliensis’ sp. nov., ‘Sutturella timonensis’ sp. nov., ‘Enorma phocaeensis’ sp. nov., ‘Mailhella massiliensis’ gen. nov., sp. nov., ‘Mordavella massiliensis’ gen. nov., sp. nov. and ‘Massiliprevotella massiliensis’ gen. nov., sp. nov., 9 new species isolated from fresh stool samples of healthy French patients
por: Ndongo, S., et al.
Publicado: (2017)

Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics
por: Colson, Philippe, et al.
Publicado: (2022)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Olfactory and gustative disorders for the diagnosis of COVID-19
por: Boudjema, Sophia, et al.
Publicado: (2020)

Genome of a chronic osteitis-causing Clostridium tetani
por: Fournier, P-E, et al.
Publicado: (2014)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj
por: Gautret, Philippe, et al.
Publicado: (2014)

From the Hajj: it's the flu, idiot
por: Raoult, D., et al.
Publicado: (2013)

Doxycycline and eradication of microfilaremia in patients with loiasis.
por: Brouqui, P, et al.
Publicado: (2001)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant
por: Fournier, Pierre-Edouard, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Rickettsia slovaca and R. raoultii in Tick-borne Rickettsioses
por: Parola, Philippe, et al.
Publicado: (2009)

Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France
por: Cassir, Nadim, et al.
Publicado: (2022)

Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors
por: Gautret, P., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rdkds3mbpkj0qqjvlpi1onb9ob